Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre.
CONCLUSIONS: This study reflects the activity of the Swiss trophoblastic disease centre from the French-speaking part of Switzerland created in 2009, and its role as local and national reference centre, in terms of global health, for women with gestational trophoblastic disease.
PMID: 33578430 [PubMed - as supplied by publisher]
Source: Swiss Medical Weekly - Category: General Medicine Authors: Fehlmann A, Benkortbi K, Rosseel G, Meyer-Hamme U, Tille JC, Sloan-Bena F, Paoloni-Giacobino A, Rougemont AL, Bodmer A, Botsikas D, Mathevet P, Petignat P, Undurraga Malinverno M Tags: Swiss Med Wkly Source Type: research
More News: Cancer & Oncology | Chemotherapy | France Health | General Medicine | Gestational Trophoblastic Tumor | Hydatidiform Mole | Methotrexate | OBGYN | Pathology | Study | Switzerland Health | Women